![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C12N 15/09 | (2006.01) |
A61K 38/46 | (2006.01) | ||
A61P 7/00 | (2006.01) | ||
A61K 35/12 | (2015.01) | ||
A61K 35/28 | (2015.01) | ||
C07K 14/47 | (2006.01) | ||
C12N 9/22 | (2006.01) | ||
C12N 15/113 | (2010.01) |
(11) | Number of the document | 3068881 |
(13) | Kind of document | T |
(96) | European patent application number | 14861930.7 |
Date of filing the European patent application | 2014-11-13 | |
(97) | Date of publication of the European application | 2016-09-21 |
(45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
(46) | Date of publication of the claims translation | 2019-08-12 |
(86) | Number | PCT/US2014/065473 |
Date | 2014-11-13 |
(87) | Number | WO 2015/073683 |
Date | 2015-05-21 |
(30) | Number | Date | Country code |
201361903823 P | 2013-11-13 | US | |
201462042075 P | 2014-08-26 | US |
(72) |
ORKIN, Stuart H., US
REIK, Andreas, US
URNOV, Fyodor, US
|
(73) |
Children`s Medical Center Corporation,
55 Shattuck Street, Boston, MA 02115,
US
Sangamo Therapeutics, Inc., Point Richmond Tech Center 501 Canal Blvd., Suite A100, Richmond, CA 94804, US |
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Geno raiškos reguliavimas, tarpininkaujant nukleazei |
NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION |
Payment date | Validity (years) | Amount | |
2023-10-18 | 10 | 231.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-11-13 |